Ezras role in proactive health At Ezra, we believe that taking a science-first approach is the most reliable path to lasting health outcomes
Oral GLP-1 pills are not all the same
In the STEP-1 trial, semaglutide 2.4 mg produced approximately 14.9% total weight loss over 68 weeks
Overall, although a large number of studies have reported the protective effects of metformin on cell or mouse models, the results must be interpreted with considerable caution because the concentrations used in vitro are markedly higher than those in vivo
DOI: 10.1186/1743-7075-7-30 Inazu, M., & Matsumiya, T
Market signals remain moderate as these technologies are earlier in development, but the overall velocity is high given the clear strategic value of reducing dosing frequency